Globus Medical Statistics
Share Statistics
Globus Medical has 136.17M shares outstanding. The number of shares has increased by 0.59% in one year.
| Shares Outstanding | 136.17M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.56% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 135.20M |
| Failed to Deliver (FTD) Shares | 147 |
| FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 2.38M, so 1.75% of the outstanding shares have been sold short.
| Short Interest | 2.38M |
| Short % of Shares Out | 1.75% |
| Short % of Float | 1.76% |
| Short Ratio (days to cover) | 2.85 |
Valuation Ratios
The PE ratio is 49.05 and the forward PE ratio is 24.39. Globus Medical 's PEG ratio is 0.14.
| PE Ratio | 49.05 |
| Forward PE | 24.39 |
| PS Ratio | 3.84 |
| Forward PS | 4.2 |
| PB Ratio | 1.51 |
| P/FCF Ratio | 36.47 |
| PEG Ratio | 0.14 |
Enterprise Valuation
Globus Medical Inc. has an Enterprise Value (EV) of 6.08B.
| EV / Earnings | 49.48 |
| EV / Sales | 3.88 |
| EV / EBITDA | 17.54 |
| EV / EBIT | 45.66 |
| EV / FCF | 36.8 |
Financial Position
The company has a current ratio of 4.88, with a Debt / Equity ratio of 0.1.
| Current Ratio | 4.88 |
| Quick Ratio | 2.72 |
| Debt / Equity | 0.1 |
| Total Debt / Capitalization | 9.45 |
| Cash Flow / Debt | 0.58 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is 0.03% and return on capital (ROIC) is 2.19%.
| Return on Equity (ROE) | 0.03% |
| Return on Assets (ROA) | 0.02% |
| Return on Capital (ROIC) | 2.19% |
| Revenue Per Employee | 313.70K |
| Profits Per Employee | 24.57K |
| Employee Count | 5.00K |
| Asset Turnover | 0.31 |
| Inventory Turnover | 0.65 |
Taxes
| Income Tax | 42.52M |
| Effective Tax Rate | 0.26 |
Stock Price Statistics
The stock price has increased by 58.98% in the last 52 weeks. The beta is 1.17, so Globus Medical 's price volatility has been higher than the market average.
| Beta | 1.17 |
| 52-Week Price Change | 58.98% |
| 50-Day Moving Average | 82.78 |
| 200-Day Moving Average | 70.32 |
| Relative Strength Index (RSI) | 69.93 |
| Average Volume (20 Days) | 1.00M |
Income Statement
In the last 12 months, Globus Medical had revenue of 1.57B and earned 122.87M in profits. Earnings per share was 1.09.
| Revenue | 1.57B |
| Gross Profit | 1.02B |
| Operating Income | 133.14M |
| Net Income | 122.87M |
| EBITDA | 346.58M |
| EBIT | 133.14M |
| Earnings Per Share (EPS) | 1.09 |
Balance Sheet
The company has 467.29M in cash and 520.40M in debt, giving a net cash position of -53.11M.
| Cash & Cash Equivalents | 467.29M |
| Total Debt | 520.40M |
| Net Cash | -53.11M |
| Retained Earnings | 1.14B |
| Total Assets | 5.09B |
| Working Capital | 1.24B |
Cash Flow
In the last 12 months, operating cash flow was 243.50M and capital expenditures -78.27M, giving a free cash flow of 165.22M.
| Operating Cash Flow | 243.50M |
| Capital Expenditures | -78.27M |
| Free Cash Flow | 165.22M |
| FCF Per Share | 1.46 |
Margins
Gross margin is 65.05%, with operating and profit margins of 8.49% and 7.83%.
| Gross Margin | 65.05% |
| Operating Margin | 8.49% |
| Pretax Margin | 10.54% |
| Profit Margin | 7.83% |
| EBITDA Margin | 22.1% |
| EBIT Margin | 8.49% |
| FCF Margin | 10.53% |
Dividends & Yields
GMED does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 1.24% |
| FCF Yield | 1.38% |
Analyst Forecast
The average price target for GMED is $94, which is 6.8% higher than the current price. The consensus rating is "Buy".
| Price Target | $94 |
| Price Target Difference | 6.8% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
Scores
| Altman Z-Score | 7.91 |
| Piotroski F-Score | 6 |